| Product Code: ETC7913761 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Irritable Bowel Syndrome Treatment Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Irritable Bowel Syndrome Treatment Market - Industry Life Cycle |
3.4 Latvia Irritable Bowel Syndrome Treatment Market - Porter's Five Forces |
3.5 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Latvia Irritable Bowel Syndrome Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about irritable bowel syndrome (IBS) and available treatment options in Latvia |
4.2.2 Rising prevalence of IBS in the population, leading to a higher demand for treatment |
4.2.3 Technological advancements in IBS treatment methods, making them more effective and accessible |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare professionals for IBS diagnosis and treatment in Latvia |
4.3.2 High cost of IBS treatment options, which may deter some patients from seeking proper care |
4.3.3 Lack of comprehensive insurance coverage for IBS treatments, affecting affordability for patients |
5 Latvia Irritable Bowel Syndrome Treatment Market Trends |
6 Latvia Irritable Bowel Syndrome Treatment Market, By Types |
6.1 Latvia Irritable Bowel Syndrome Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By IBS-C, 2021- 2031F |
6.1.4 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By IBS-D, 2021- 2031F |
6.2 Latvia Irritable Bowel Syndrome Treatment Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Xifaxan, 2021- 2031F |
6.2.3 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Linzess/Constella, 2021- 2031F |
6.2.4 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Viberzi, 2021- 2031F |
6.2.5 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Amitiza, 2021- 2031F |
6.2.6 Latvia Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Irritable Bowel Syndrome Treatment Market Import-Export Trade Statistics |
7.1 Latvia Irritable Bowel Syndrome Treatment Market Export to Major Countries |
7.2 Latvia Irritable Bowel Syndrome Treatment Market Imports from Major Countries |
8 Latvia Irritable Bowel Syndrome Treatment Market Key Performance Indicators |
8.1 Average waiting time for IBS diagnosis and treatment in healthcare facilities |
8.2 Number of healthcare facilities offering specialized IBS treatment services |
8.3 Patient satisfaction rates with IBS treatment options available in Latvia |
9 Latvia Irritable Bowel Syndrome Treatment Market - Opportunity Assessment |
9.1 Latvia Irritable Bowel Syndrome Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Irritable Bowel Syndrome Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Latvia Irritable Bowel Syndrome Treatment Market - Competitive Landscape |
10.1 Latvia Irritable Bowel Syndrome Treatment Market Revenue Share, By Companies, 2024 |
10.2 Latvia Irritable Bowel Syndrome Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |